Drug Research

Suven Life Sciences Ltd announces that the grant of one (1) product patent from Eurasia (025136) and one (1) product patent from Norway (339034) corresponding to the New Chemical…
Read More...

Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and…
Read More...

Ligand Pharmaceuticals announces it has entered into global license and supply agreements with Novartis for the development and commercialization of a Captisol-enabled oral liquid…
Read More...

Menarini-Silicon Biosystems said its DEPArray single-cell isolation technology played an important role in a study carried out by researchers from The University of Manchester to…
Read More...

Tillotts Pharma has introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists. The…
Read More...

PAREXEL International has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies. LIQUENT InSight for IDMP is the newest module…
Read More...

UK artificial intelligence (AI) firm BenevolentAI has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen Pharmaceutica (Janssen), one of the…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of…
Read More...

ERS Genomics and Knudra Transgenics have signed a non-exclusive license agreement on CRISPR-Cas9 genome editing patents for model organisms. The deal provides Knudra with worldwide…
Read More...

IBM announced that many IBM U.S. employees fighting cancer will be able to tap into Watson for insights into their cancer treatment as well as potential clinical trial options. Through…
Read More...

Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition. Kinases are enzymes that regulate essential cellular…
Read More...

Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a…
Read More...

Bayer and DelSiTech Ltd., a Finnish drug delivery technology and drug development company, have signed a Collaboration and Technology Licence Agreement for the worldwide application of…
Read More...

Ligand Pharmaceuticals has entered into a worldwide license agreement with Menlo Park, CA-based TeneoBio. Under the license, TeneoBio will be able to use the OmniFlic technology from…
Read More...

Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced the effectiveness of the exclusive licensing…
Read More...

Genmab has entered an agreement to grant Gilead Sciences an exclusive license and an option on a second exclusive license, to use the DuoBody technology platform to create and develop…
Read More...

Lantern Pharma has entered into an exclusive agreement to evaluate BioNumerik Pharmaceuticals' Tavocept for human therapeutic indications using Lantern’s 5-M theranostic platform.…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced the award of a $2 million research grant from the FDA’s Office of Orphan…
Read More...

Medidata announced that its cloud technology platform has been adopted by Pluristem Therapeutics. The Israeli biotech will deploy Medidata Rave to capture, manage and maximize the value…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion…
Read More...